Alive via autophagy

By examining mouse embryonic fibroblasts, molecular biologist Gregg Semenza of The Johns Hopkins University School of Medicine and colleagues found that cells use autophagy to survive low oxygen conditions.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:
H. Zhang, et al., “Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia,” J Biol Chem, 283:10892–903, 2008. (Cited in 72 papers)

The finding:
By examining mouse embryonic fibroblasts, molecular biologist Gregg Semenza of The Johns Hopkins University School of Medicine and colleagues found that cells use autophagy to survive low oxygen conditions. Specifically, they showed that cells digest their mitochondria—a process known as mitochondrial autophagy—when deprived of oxygen, thereby halting oxidative metabolism, which would normally produce extra reactive oxygen species (ROS) during hypoxia. “The [cessation of oxidative metabolism] occurs not because there’s not enough oxygen to generate ATP, but to do so under hypoxic conditions would generate so much ROS, you’d kill the cell,” Semenza says.

The surprise: “For the last 5 years or more, autophagy has been seen as a cell death process,” says cell biologist Jacques Pouysségur of the Institute of Developmental Biology and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies